Page last updated: 2024-10-22

am 580 and Diabetes Mellitus, Type 2

am 580 has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Am 580: a selctive retinoic acid receptor (alpha) agonist; structure given in first source
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid : An amidobenzoic acid obtained by formal condensation of the carboxy group of (5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)benzoic acid with the anilino group of 4-aminobenzoic acid. A selective RARalpha agonist.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guleria, RS1
Singh, AB1
Nizamutdinova, IT1
Souslova, T1
Mohammad, AA1
Kendall, JA1
Baker, KM1
Pan, J1

Other Studies

1 other study available for am 580 and Diabetes Mellitus, Type 2

ArticleYear
Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats.
    Journal of molecular and cellular cardiology, 2013, Volume: 57

    Topics: Animals; Benzoates; Bexarotene; Blood Glucose; Collagen; Diabetes Mellitus, Type 2; Diabetic Cardiom

2013